Terms: = Lymphoma AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Clinical Outcome
3 results:
1. Matrix metalloproteinases and their tissue inhibitors - expression, role and regulation in human malignant non-Hodgkin's lymphomas.
Kossakowska AE; Urbanski SJ; Janowska-Wieczorek A
Leuk Lymphoma; 2000 Nov; 39(5-6):485-93. PubMed ID: 11342332
[TBL] [Abstract] [Full Text] [Related]
2. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (timp-1) expression in malignant non-Hodgkin's lymphomas.
Kossakowska AE; Edwards DR; Prusinkiewicz C; Zhang MC; Guo D; Urbanski SJ; Grogan T; Marquez LA; Janowska-Wieczorek A
Blood; 1999 Sep; 94(6):2080-9. PubMed ID: 10477738
[TBL] [Abstract] [Full Text] [Related]
3. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
Hansen PB; Penkowa M; Johnsen HE
Leuk Lymphoma; 1998 Feb; 28(5-6):491-500. PubMed ID: 9613978
[TBL] [Abstract] [Full Text] [Related]
